atopic dermatitis msd ped point of view_dr. nia

34
Nia Kurniati

Upload: kgs-mahendra-effendy-ii

Post on 13-Dec-2015

222 views

Category:

Documents


0 download

DESCRIPTION

Atopic Dermatitis

TRANSCRIPT

Page 1: Atopic Dermatitis MSD PEd Point of View_dr. Nia

Nia Kurniati

Page 2: Atopic Dermatitis MSD PEd Point of View_dr. Nia

• Pediatrician encounter 1 out of 10-15 patient with skin problems in OPD

• Generally they understand how to diagnose and deliver basic management

• There are many things that is not direct

Page 3: Atopic Dermatitis MSD PEd Point of View_dr. Nia

• Related to “Atopic March”: § As first step

• Around 75-80% will develop allergic rhinitis in later life

• Around 50% will develop asthma

Leung, JACI 2003 (Suppl): S117

Page 4: Atopic Dermatitis MSD PEd Point of View_dr. Nia

Bieber T. Atopic dermatitis. N Engl J Med 2008;358:1491.

Page 5: Atopic Dermatitis MSD PEd Point of View_dr. Nia
Page 6: Atopic Dermatitis MSD PEd Point of View_dr. Nia

ADULT

12 > y.o - adult

CHILDHOOD

2-12 y.o

INFANTILE baby- 2

y.o.

Page 7: Atopic Dermatitis MSD PEd Point of View_dr. Nia
Page 8: Atopic Dermatitis MSD PEd Point of View_dr. Nia
Page 9: Atopic Dermatitis MSD PEd Point of View_dr. Nia

• more dry lesion • more chronic itch scratch lichenification • Recurrence acute erythema, plaque

infiltrate, papules dan erosion • Location in hand, feet, wrist & ankle • Lesion in flexural antecubital & popliteal main sign

Page 10: Atopic Dermatitis MSD PEd Point of View_dr. Nia
Page 11: Atopic Dermatitis MSD PEd Point of View_dr. Nia

William Criteria

Basic feature (obligatory) • Itchy skin

• Skin symptoms in flexural regions & neck (cheeks in children < 10 years)

• Asthma / allergic rhinitis (or atopic diseases in close relatives in children < 4 years)

• Dry skin during the last years • Visible eczema in flexural areas (or on cheeks and/or

forehead in chlidren < 4 years) • Eczema starting before age 2

Additional features

Diagnosis : Itchy skin + minimal 3 of the additional features

Page 12: Atopic Dermatitis MSD PEd Point of View_dr. Nia

ASSESING DISEASE SEVERITY

Page 13: Atopic Dermatitis MSD PEd Point of View_dr. Nia

• Developed by ETFAD on 1993

• Maximum score is 103

•0-34 MILD

•35

-69 MODERATE

•70

-103

SEVERE

Pediatrician do not practice this

Page 14: Atopic Dermatitis MSD PEd Point of View_dr. Nia

Modified Qualitative Scoring for AD – Developed by Prof. Thiru THIRUMOORTHY

Classification of Severity in the Clinic to guide the Intensity of Treatment required

Episodic Localised Flexural (2 or less flexures)

Episodic Extensive Flexural

Persistent Extensive Flexural

Persistent Extensive Flexural & Non-flexural

Generalised Atopic dermatitis – childhood

Generalised Atopic dermatitis – adulthood

Redness – None, Mild, Moderate, Severe Swelling(edema) – None, Mild, Moderate, Severe Oozing / crusting – None, Mild, Moderate, Severe Scratch marks(excoriation) – None, Scattered, Disseminated, Severe Skin thickening (lichenification) None, Mild, Moderate, Severe

Asses the most dominant sign found

None=0; Mild=1; Moderate=2; Severe=3

Page 15: Atopic Dermatitis MSD PEd Point of View_dr. Nia

• Clinical impression of the extend of the lesion • Recurrent and persistent lesion

Page 16: Atopic Dermatitis MSD PEd Point of View_dr. Nia
Page 17: Atopic Dermatitis MSD PEd Point of View_dr. Nia

Standard Treatment: skin hydration, emollient, avoid irritant, identify and

avoid aggravating factor

Systemic Therapy (e.g: Cyclosporin A) or UV therapy

TCS moderate-super potent and/or TCI

TCS mild-moderate and/or TCI

DA severe,recalsitran

DA moderate-severe

DA mild - moderate

Dry Skin Only

4

3

2

1

TCS: topical corticosteroid ; TCI: topical calcineurin inhibitor

Page 18: Atopic Dermatitis MSD PEd Point of View_dr. Nia

1. Education and empowerment of patients and caregiver(s) 1. Eczema school/eczema camps

2. Avoidance and modification of environmental trigger factors 1. Lifestyle modification 2. Avoidance of skin injury 3. Rebuilding and maintenance of optimal barrier

function 4. Clearance of inflammatory skin disorders 5. Control and elimination of the itch–scratch cycle

Rubel D, et al. Consensu guideline for the management of Atopic Dermatitis: An

Page 19: Atopic Dermatitis MSD PEd Point of View_dr. Nia

Asia-Pacific perspectives. J Dermatol 2013;40:161-70

Recognize trigger factors Use of standardize lists ( house dust mite,

chemical substance, 5 food)

Clearance of inflammatory skin disorders Use of Topical Corticosteroid (TCS)

Control and elimination of the itch–scratch cycle Oral antihistamine

Page 20: Atopic Dermatitis MSD PEd Point of View_dr. Nia

1. Education and empowerment of patients and caregiver(s)

2. Avoidance and modification of environmental trigger factors

1. Lifestyle modification

2. Avoidance of skin injury

3. Rebuilding and maintenance of optimal barrier function

4. Clearance of inflammatory skin disorders

5. Control and elimination of the itch–scratch cycle

Page 21: Atopic Dermatitis MSD PEd Point of View_dr. Nia

It could be an easy or hardest part History taking---taking time

Allergy tests --- are not in straight causal relationship (positive result doesn’t translate as the cause of AD, negative result is often misleading)

The patient (and family) should have discipline to avoid trigger factors Develop a relationship with the family

Page 22: Atopic Dermatitis MSD PEd Point of View_dr. Nia

Severity of

AD

Inhalant and/or food allergen

Food allergen only

Mild 15% 20%

Moderate 18% 26%

Severe 20% 45%

Patrizi A, et al. The natural history of sensitizations to food and aeroallergens in atopic dermatitis: a 4-year follow up, Pediatr Dermatol 2000;17:261-5

Page 23: Atopic Dermatitis MSD PEd Point of View_dr. Nia

Severity of AD Inhalant and/or food allergen

Food allergen only

Asthma and/ or allergic rhinitis

Mild 31% 6% 15%

Moderate 52% 6% 32%

Severe 100% 0% 75% Patrizi A, et al. The natural history of sensitizations to food and aeroallergens in atopic dermatitis: a 4-year follow up, Pediatr Dermatol 2000;17:261-5

Page 24: Atopic Dermatitis MSD PEd Point of View_dr. Nia
Page 25: Atopic Dermatitis MSD PEd Point of View_dr. Nia

Topical Corticosteroid, Topical Calcineurin, systemic

The wise ways to choose corticosteroid

Correct indication and know the contraindication Choose the appropriate potency

Minimal side effects

Acceptability

Cost and benefit

Page 26: Atopic Dermatitis MSD PEd Point of View_dr. Nia
Page 27: Atopic Dermatitis MSD PEd Point of View_dr. Nia

C27H30Cl2O6

9α,21-dichloro-11β, 17 α -dihydroxy-16 α -methylpregna- 1,4 diene-3,20 dione 17-(2- furoate) 1 http:/ / www.chemspider.com/ ImageView.aspx?mode=3d&id=390091

Page 28: Atopic Dermatitis MSD PEd Point of View_dr. Nia

27

Need to address concerns regarding steroid phobia

If used correctly, AEs such as suppression of adrenal function, diabetes mellitus, and moon face

Low potential for skin atrophy with mometasone and fluticasone in children/adults

1 Hanifin J, et al. Br J Dermatol 2002;147:528-537; 2Berth-Jones J, et al. BMJ 2003;326:1367.3Hong E, et al. Pediatr Dermatol 2011;28:393-396; 4Saeki H, et al. J Dermatol 2009;36:563-577.

Page 29: Atopic Dermatitis MSD PEd Point of View_dr. Nia

• Acute• Chronic (maintenance): intermittent, week end, hot

spot, has proven to control inflammation in recalcitrant cases

Page 30: Atopic Dermatitis MSD PEd Point of View_dr. Nia

A number of defects in innate cutaneous immunology may explain the high rate of cutaneous

colonization with Staphylococcus aureus in AD

Page 31: Atopic Dermatitis MSD PEd Point of View_dr. Nia

• This led to the clinical concept that patients with high numbers of colonizing S. aureus can benefit

from combination treatment with corticosteroids and antimicrobial treatment (Diprogenta®)

Improving eczema with anti-inflammatory regimen decreases staphyloccocal colonization.

Page 32: Atopic Dermatitis MSD PEd Point of View_dr. Nia
Page 33: Atopic Dermatitis MSD PEd Point of View_dr. Nia

TCIs=topical calcineurin inhibitors; TCS=topical corticosteroids

Journal of Dermatology 2013; 40: 160–171

Page 34: Atopic Dermatitis MSD PEd Point of View_dr. Nia

• Atopic Dermatitis is an important step in allergic march in children

• Stepwise management also apply in children, with emphasis on triggering factors management